WASHINGTON, D.C. / RankWire.AI / – Patients who had their appendix removed due to acute appendicitis experienced fewer diagnoses of colorectal cancer compared to similar individuals treated solely with antibiotics. Researchers analyzed matched patient groups within a large global health database. The data showed that 0.7% of patients who underwent an appendectomy developed colorectal cancer, whereas 1.7% of those treated only with antibiotics did. This difference translated to a 58% lower relative risk for the surgical group. It’s important to note that these findings indicate an association, not a direct proof that appendectomy prevents colorectal cancer.
The study utilized the TriNetX Global Collaborative Network, which encompasses data from 168 healthcare organizations. Researchers identified individuals with acute appendicitis who received either surgical removal or antibiotics. Matching procedures resulted in two initial cohorts of 15,774 patients each. After excluding patients with prior colorectal cancer diagnoses, the final analysis involved 15,616 surgical patients and 15,295 antibiotic-treated patients. Within these groups, 110 cases of colorectal cancer appeared in the appendectomy cohort, compared to 254 cases among those treated only with antibiotics.
The American College of Surgeons showcased this research during its 2026 Clinical Congress in Washington, held from Sept. 26 to Sept. 29. The study was included in the Scientific Forum program following review for presentation at the conference. However, it has not undergone peer review in a medical journal. This status remains significant when evaluating the results. The researchers did not claim that appendix removal directly reduces cancer risk, nor did the study test appendectomy specifically as a preventative measure against colorectal cancer.
Investigation explores different treatment options after appendicitis
Acute appendicitis occurs when the appendix becomes inflamed, often necessitating urgent medical intervention. Usually, doctors perform surgery to remove the appendix, but antibiotics can be an alternative for certain uncomplicated cases. The comparison in this new research was based on these two treatment approaches. Valentine Nfonsam of Morehouse School of Medicine served as the senior author. He emphasized that antibiotic therapy remains a vital option for suitable patients, despite the lower incidence of later colorectal cancer diagnoses observed in the surgical group.
The study also examined clinical factors that could influence the link between appendicitis and colorectal cancer. In some cases, an undiagnosed tumor in the right colon may contribute to inflammation of the appendix. Surgical removal allows for tissue examination by a pathologist, which can uncover abnormalities and lead to further testing. Patients treated solely with antibiotics do not typically have tissue examined at the time of treatment, creating a notable difference in how potential disease can be detected.
Findings do not establish a definitive protective effect against cancer
The appendix contains immune-related tissue and plays a role in the intestinal environment. It has also been studied in relation to the gut microbiome, which includes microorganisms residing in the digestive tract. The current analysis did not determine whether these biological factors explain the variation in colorectal cancer diagnoses. Additionally, the researchers did not establish inflammation, microbiome alterations, or immune responses as causes for the observed difference. Consequently, the study supports an association between treatment type and later diagnosis rates, but not a confirmed protective effect from surgery.
Previous studies have yielded mixed results regarding appendectomy and long-term colorectal cancer risk. A 2024 prospective analysis tracked over 224,000 participants across three major cohorts for up to 32 years. That research found no evidence linking appendectomy with increased long-term colorectal cancer risk or precancerous conditions. This new study narrows the focus, comparing patients treated for acute appendicitis with surgery against matched patients receiving only antibiotics. Known risk factors for colorectal cancer still include age, family history, and genetic predispositions.